These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8713431)

  • 1. [Action of lovastatin--an inhibitor of cholesterol biosynthesis on bacterial bioluminescence].
    Baranova NA; Krĕier VG; Egorov NS
    Antibiot Khimioter; 1995 Aug; 40(8):12-6. PubMed ID: 8713431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations.
    Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF
    Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
    Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
    Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The growth of Rhodotorula rubra yeasts and their synthesis of ergosterol on media with lovastatin].
    Baranova NA; Kreĭner VG; Egorov NS
    Antibiot Khimioter; 1996; 41(11):3-6. PubMed ID: 9214284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW; Jung SE
    J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    Alberts AW; Chen J; Kuron G; Hunt V; Huff J; Hoffman C; Rothrock J; Lopez M; Joshua H; Harris E; Patchett A; Monaghan R; Currie S; Stapley E; Albers-Schonberg G; Hensens O; Hirshfield J; Hoogsteen K; Liesch J; Springer J
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3957-61. PubMed ID: 6933445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Sliskovic DR; Blankley CJ; Krause BR; Newton RS; Picard JA; Roark WH; Roth BD; Sekerke C; Shaw MK; Stanfield RL
    J Med Chem; 1992 May; 35(11):2095-103. PubMed ID: 1597859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells.
    Yanagita T; Yamamoto K; Ishida S; Sonda K; Morito F; Saku K; Sakai T
    Clin Ther; 1994; 16(2):200-8. PubMed ID: 8062316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocholesterolemic agents.
    Endo A
    Biotechnology; 1994; 26():301-20. PubMed ID: 7749309
    [No Abstract]   [Full Text] [Related]  

  • 12. Compactin-a review.
    Chakravarti R; Sahai V
    Appl Microbiol Biotechnol; 2004 Jun; 64(5):618-24. PubMed ID: 15034683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simvastatin].
    Burgmer U; Mohr K
    Dtsch Med Wochenschr; 1996 Jun; 121(23):769-70. PubMed ID: 8646995
    [No Abstract]   [Full Text] [Related]  

  • 14. A gift from nature: the birth of the statins.
    Endo A
    Nat Med; 2008 Oct; 14(10):1050-2. PubMed ID: 18841147
    [No Abstract]   [Full Text] [Related]  

  • 15. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors unmask cryptic regulatory mechanisms.
    Lopez D; Chambers CM; Ness GC
    Arch Biochem Biophys; 1997 Jul; 343(1):118-22. PubMed ID: 9210653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering.
    Hughes AD
    J Hum Hypertens; 1996 Jun; 10(6):387-90. PubMed ID: 8872802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F; Watanabe Y; Hayaishi O
    Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol-fed rats.
    Lee JS; Jeon SM; Park EM; Huh TL; Kwon OS; Lee MK; Choi MS
    J Med Food; 2003; 6(3):183-91. PubMed ID: 14585184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesis.
    Berkhout TA; Simon HM; Jackson B; Yates J; Pearce N; Groot PH; Bentzen C; Niesor E; Kerns WD; Suckling KE
    Atherosclerosis; 1997 Sep; 133(2):203-12. PubMed ID: 9298680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.